Two brokers view Chularat Hospital (CHG) as entering a recovery phase in the second half of 2026. Land and House Securities maintains its 2026 revenue growth forecast at a mid-single-digit level, expecting the second half to outperform the first half, as July revenue accelerated by about 5% year-on-year, driven by general patients and government project revenue, while foreign patients are beginning to recover. The third-quarter profit is expected to recover both year-on-year and quarter-on-quarter, due to the high season for seasonal diseases and a trend of reduced losses at Mae Sot Hospital. The broker recommends buying on weakness with a target price of 1.91 baht. Trinity Securities notes that first-half revenue was pressured by fewer gastrectomy cases, but expects third and fourth quarters to recover seasonally. It forecasts 2026 profit of 995 million baht, up 7% year-on-year, with a buy recommendation and a target price of 2.00 baht, based on discounted cash flow with a weighted average cost of capital of 8.7%.
Chularat Hospital Public Company LimitedBrokers expect recovery in H2 2026 driven by general patients, government project revenue, and foreign patient recovery, with Q3 profit recovering on seasonal diseases and reduced losses at Mae Sot Hospital.
